Osteoarthritis in horses - Part 2: a review of the intra-articular use of corticosteroids as a method of treatment
AUTOR(ES)
Souza, Maria Verônica de
FONTE
Braz. arch. biol. technol.
DATA DE PUBLICAÇÃO
20/06/2016
RESUMO
ABSTRACT: The problem considered in this review is related to the frequent use of corticosteroids (COs) (i.e. steroids) in the practice of equine medicine and surgery as a therapeutic strategy in the treatment of degenerative joint disease, commonly known as osteoarthritis (OA). This disease is one of the most common among the equine musculoskeletal diseases, and is clinically characterized by pain, lameness, joint effusion at the initial stage, which usually reduces with the progression of the disease, and reduced physical performance. Although steroids are considered excellent drugs in the control of clinical signs resulting from osteoarthritis, they also influence cellular activity through activation of various signaling mechanisms. However, they can cause adverse effects when administered intra-articularly, since they are immunosuppressive drugs of many cell types. They are also incriminated as suppressors of the chondrocyte matrix synthetic activities, which may contribute to 'arthropathy by corticosteroids', which can also be associated with cumulative injury resulting from improper use (dose and frequency of application) of already damaged joints. The objective of this article is to review information about the advantages and disadvantages of intra-articular COs for treatment of the disease in horses. In addition, some important information of other species is also presented.
Documentos Relacionados
- Intra-articular corticosteroids are effective in osteoarthritis but there are no clinical predictors of response.
- Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis
- Value of Intra-Articular Injections in Osteo-Arthritis: A Controlled Series
- Comparison of Intra-Articular Cortisone Analogues in Osteo-Arthritis of the Knee
- Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action